Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Poor sleep in patients with multiple sclerosis.
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Fingolimod phosphate promotes the neuroprotective effects of microglia.
lipid-specific IgM bands in csf associated with a reduced risk of developing pml during treatment with natalizumab.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
ALAIN01-Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.

Pages